Menlo Park, CA – Octave Bioscience Inc. has announced the appointment of Zachary Fernandes as Vice President Business Development. About Octave Bioscience Inc.: Octave Bioscience Inc. is a healthcare technology company focused on advancing precision neurology, beginning with improved care for people living with multiple sclerosis (MS). The company develops and delivers the Octave MSDA Test, a first-of-its-kind, multi-analyte blood test that measures 18 biomarkers to quantify MS disease activity and provide a single score from 1 to 10 reflecting current disease status. Using advanced machine learning and a large clinical data set, Octave integrates biomarker data with patients medical histories and symptoms to give clinicians deeper, data-driven insights that go beyond what traditional imaging, such as MRI, can show. Octave positions itself as an extension of the neurology clinic through its broader Clinical Insights Program, designed to help providers continuously manage and monitor MS patients wherever they are. Built on decades of research, sophisticated molecular testing, and a mission to illuminate the path forward in neurodegenerative disease, Octave is initially focused on MS but aspires to expand its precision neurology platform to other conditions such as Parkinsons and Alzheimers disease.

For more information visit: https://www.octavebio.com/

Octave Bioscience Inc.
1440 O’Brien Drive Suite B
Menlo Park, CA 94025
Phone: 650-459-0942
LinkedIn: https://www.linkedin.com/company/octave-bio/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved